IXICO (LON:IXI) Stock Price Up 13.5% – What’s Next?

IXICO plc (LON:IXI) traded up 13.5% during trading on Tuesday . The company traded as high as GBX 9.50 and last traded at GBX 9.22. Approximately 428,679 shares were traded during mid-day trading, an increase of 245% from the average daily volume of 124,079 shares. The stock had previously closed at GBX 8.12.

IXICO Stock Performance

The company has a quick ratio of 4.90, a current ratio of 2.83 and a debt-to-equity ratio of 5.22. The company has a market cap of £19.92 million, a price-to-earnings ratio of -4.67, a PEG ratio of -0.38 and a beta of 0.13. The firm has a 50 day moving average price of GBX 8.07 and a two-hundred day moving average price of GBX 8.80.

IXICO (LON:IXI) last posted its quarterly earnings data on Tuesday, May 19th. The company reported GBX (1.21) EPS for the quarter. IXICO had a negative return on equity of 16.18% and a negative net margin of 24.98%.The company had revenue of GBX 395 million during the quarter. As a group, equities analysts forecast that IXICO plc will post -289.3584879 earnings per share for the current year.

IXICO Company Profile

IXICO is a global leader in neuroscience imaging and biomarker analytics, using its proprietary AI-driven platform to help advance the treatment of neurological disorders and reduce the uncertainties associated with drug discovery, development and monitoring.

By unlocking valuable insights into drug safety and efficacy, IXICO has built a global reputation and 20-year track record as an end-to-end Imaging Contract Research Organisation (iCRO) managing and analysing neurological clinical trials.